23.04.2015 Views

Item 12 – Infection control HCAI update - East and North Herts NHS ...

Item 12 – Infection control HCAI update - East and North Herts NHS ...

Item 12 – Infection control HCAI update - East and North Herts NHS ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Trust Board<br />

<strong>HCAI</strong> <strong>update</strong><br />

May 28, 2008<br />

Noel Scanlon<br />

Director of <strong>Infection</strong> prevention & Control / Director of Nursing<br />

James Quinn<br />

Medical Director<br />

Lorane Fitch<br />

Lead Doctor, <strong>Infection</strong> <strong>control</strong><br />

Kevin Hazelwood<br />

Antimicrobial pharmacist


MRSA target & performance 2008/9<br />

MRSA bacteraemia incidence* v. target<br />

100<br />

90<br />

No. of MRSA bacteraemias<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

2001 / 02 2002 / 03 2003 / 04 2004 / 05 2005 / 06 2006 / 07 YTD 2007/8 target 2008/9<br />

Target 0 0 56 48 39 31 22 21<br />

Actual 72 86 56 50 56 53 33 2<br />

Year<br />

Target<br />

Actual<br />

<strong>Infection</strong>s in<br />

year to date<br />

April 30,<br />

2008<br />

UNVALIDA<br />

TED<br />

2<br />

MRSA/<strong>HCAI</strong> report to Board


Monthly performance vs Recovery trajectory 2008/9<br />

Cases M RSA Bacteraem ia<br />

3<br />

2<br />

1<br />

0<br />

Incidence v recovery trajectory MRSA Bacteraemia<br />

E&N <strong>Herts</strong> <strong>NHS</strong> Trust 2008/9<br />

Apr May June July Aug Sept Oct Nov Dec Jan Feb Mar<br />

Month<br />

Post 48 hour Pre 48 hour Trajectory 2008/9<br />

3<br />

MRSA/<strong>HCAI</strong> report to Board


MRSA cumulative performance 2006/7, 2007/8 & 2008/9<br />

MRSA Bacteraemia Cumulative performance 2006/7 & 2007/8<br />

60<br />

50<br />

40<br />

34%<br />

reduction<br />

FYTD<br />

2006/7 to<br />

2007/8<br />

month<br />

30<br />

20<br />

10<br />

0<br />

Apr May Jun Jul Aug Sept Oct Nov Dec Jan Feb Mar<br />

MRSA Bacteraemias<br />

2006/7<br />

2007/8<br />

2008/9<br />

4<br />

MRSA/<strong>HCAI</strong> report to Board


Incidence & Prevalence MRSA Bacteraemia 2007-8<br />

Not Set<br />

3%<br />

Trauma &<br />

orthopaedics<br />

6%<br />

ICU<br />

9%<br />

HDU<br />

6%<br />

Cardiology<br />

6% Colorectal surgery<br />

6%<br />

Gastroenterology<br />

3%<br />

Nephrology<br />

<strong>12</strong>%<br />

General medicine<br />

25%<br />

Geriatric medicine<br />

15%<br />

General surgery<br />

9%<br />

5<br />

MRSA/<strong>HCAI</strong> report to Board


Root causes of MRSA bacteraemia 2007-8<br />

Risk factors in MRSA Bacteramias 2007_8 RCAs 2007_8<br />

Unavoidable pre 48 hr<br />

6%<br />

Ab use<br />

11%<br />

Contams prob/pos<br />

19%<br />

Screening issue<br />

15%<br />

PVC<br />

9%<br />

Unknown<br />

6%<br />

Other<br />

9%<br />

Urine<br />

2%<br />

Surg wound<br />

6%<br />

CVC/fem/art<br />

17%<br />

6<br />

MRSA/<strong>HCAI</strong> report to Board


Key actions<br />

‣ Blood culture care bundle including<br />

• packs containing Chloraprep 0.7ml<br />

vial with<br />

• ICE order comms care bundle &<br />

training check<br />

• Sanction of not processing blood<br />

culture unless completed<br />

‣ Peripheral line packs<br />

• M<strong>and</strong>ating aseptic technique with a<br />

dressing trolley<br />

• Making recording date of insertion<br />

to facilitate regular VIP score <strong>and</strong><br />

removal at 48-72h<br />

o In case notes<br />

o Beside IV line dressing<br />

7<br />

MRSA/<strong>HCAI</strong> report to Board


Clostridium difficile incidence 2004/5 to date<br />

v targets 2007/8 <strong>and</strong> 2008/9<br />

700<br />

600<br />

563 574<br />

500<br />

414<br />

400<br />

300<br />

200<br />

356<br />

183<br />

C Diff<br />

incidence<br />

Track line<br />

target<br />

New track line<br />

2008/9 target<br />

Linear (Track<br />

line target)<br />

100<br />

0<br />

2005/6 2006/7 2007/8* 2008/9 2007/8<br />

Target<br />

18<br />

2008/9<br />

Target<br />

8<br />

*ytd April 30, 2008 unvalidated<br />

MRSA/<strong>HCAI</strong> report to Board


Clostridium difficile performance * v trajectory/target 2008/9‡<br />

‡ inc. all Hosp. Acquired cases over 2yo not<br />

just >65yo observed at >48h admission<br />

Incidence v recovery trajectory Clostridium difficile E&N <strong>Herts</strong> <strong>NHS</strong> Trust 2007/8<br />

40<br />

35<br />

Cases in patients over 65 yo<br />

30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

Apr May June July Aug Sept Oct Nov Dec Jan Feb Mar<br />

Month<br />

"Hospital Inpatient" specimens "Not Hospital Inpatient" specimens Local trajectory 2008/9<br />

9<br />

MRSA/<strong>HCAI</strong> report to Board


Root cause analyses Clostridium difficile assoc. diarrhoea<br />

(CDAD) April<br />

‣ Three deaths with CDAD<br />

• One of these where CDAD cited as 1a cause of death (CoD),<br />

• one as 2 CoD<br />

‣ 15 cases in April subject to remote Root cause analysis<br />

• Antibiotics implicated in 9 cases<br />

o<br />

Only one of these Cephalsporins, none with Quinnolones<br />

o 8 involving v long courses of Erythromycin, Augmentin, Amoxicillin – 6 – 17<br />

days<br />

– Inc. IV antbiotics for 5-11 days<br />

– One occasion for a ‘carpet burn’ IV Rx “unknown” to medical staff ?<br />

• Proton pump inhibitors implicated in 9 cases<br />

• Delays in isolation for diarrhoea of unknown cause - not presumptive or<br />

confirmed C Diff implicated in 6 cases<br />

‣ Proposing to introduce IC Consultant led RCA with Consultant I/c Matron &<br />

ward staff for all Colectomies, deaths & ICU admissions associated with<br />

CDAD wef May <strong>12</strong> th<br />

• T&O first case to trial new RCA Tool<br />

10<br />

MRSA/<strong>HCAI</strong> report to Board


Trust Care bundle (HII) compliance rates<br />

H<strong>and</strong> Hygiene<br />

Environment & Safety<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

MRSA Screening<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

Peripheral Lines<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

11<br />

MRSA/<strong>HCAI</strong> report to Board


Trust HII, h<strong>and</strong> hygiene, screening &<br />

environment scores<br />

Urinary Catheter Care<br />

Care of Renal Dialysis Patients<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

Central Venous Catheter Care<br />

Care of Ventilated Patients<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

21-Mar-08 28-Mar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

<strong>12</strong><br />

MRSA/<strong>HCAI</strong> report to Board


Isolation audits<br />

<strong>12</strong><br />

Isolated within 2hrs<br />

No<br />

Yes<br />

No. of Patients<br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

21-M ar-08 28-M ar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

No of Days to Isolate<br />

No. of BedDays<br />

20<br />

18<br />

16<br />

14<br />

<strong>12</strong><br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

21-M ar-08 28-M ar-08 04-Apr-08 11-Apr-08 18-Apr-08 25-Apr-08<br />

13<br />

MRSA/<strong>HCAI</strong> report to Board


A step change in reduction of <strong>HCAI</strong><br />

‣ The Medical Director <strong>and</strong> Director of <strong>Infection</strong> prevention <strong>and</strong> Control have<br />

considered the latest guidance from the Health Protection Agency, Hospital<br />

<strong>Infection</strong> Society <strong>and</strong> the <strong>Infection</strong> Control Nurses Association in evaluating<br />

what further steps might be taken in bringing about a step wise reduction in<br />

the incidence of health care associated infections.<br />

‣ A series of measures around the 10 key recommendations for each of the<br />

current HPA, HIS <strong>and</strong> ICNA st<strong>and</strong>ard references for Clostridium difficile <strong>and</strong><br />

MRSA reduction focus upon the major modes of transmission <strong>and</strong> portals of<br />

entry for these infections:<br />

• Surveillance<br />

• H<strong>and</strong> hygiene<br />

• Antibiotic prescribing<br />

• Isolation<br />

• Environmental cleansing <strong>and</strong> decontamination<br />

• Screening <strong>and</strong> decolonisation<br />

• Management of invasive devices<br />

• Aseptic technique.<br />

‣ This is being reviewed by the Trust infection <strong>control</strong> committee <strong>and</strong> will be<br />

brought to the Executive ctee. this month<br />

14<br />

MRSA/<strong>HCAI</strong> report to Board

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!